Drug Topics, March 18th, 2002
Generic name
Moxifloxacin IV
Proprietary name/manufacturer
AVELOX IV/Bayer
FDA-approved indications
Treatment of acute bacterial sinusitis, acute bacterial exacerbation of chronic bronchitis, community-- acquired pneumonia (CAP), and uncomplicated skin and skin structure infections caused by susceptible strains of the infecting microorganisms in adults
Pharmacology
Moxifloxacin, a third-generation fluoroquinolone antibiotic, has a broad spectrum of antimicrobial activity, including gram-positive and gram-negative organisms. Moxifloxacin's bactericidal action results from inhibition of D...
HighBeam Research, Free Preview: 'P & T portfolio: Moxifloxacin IV'... Full Membership required for unlimited access. Free 7-day trial.
Subscribers: HighBeam content is only available to HighBeam subscribers. Click the link above for more information.
